arrow
J

Joanne Ngeow

national cancer centre singapore
H指数:54
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pre‐emptive pharmacogenomics testing in clinical practice: A pilot implementation in Singapore

临床实践中预防性药物基因组学检测:新加坡试点实施方案

2026-11-050
PRE
Publisher Correction: Translating genomic data into healthcare practice with the Singapore National Precision Medicine program

出版更正:利用新加坡国家精准医学计划将基因组数据转化为医疗实践

2026-08-180
PRE
Translating genomic data into healthcare practice with the Singapore National Precision Medicine program

利用新加坡国家精准医学计划将基因组数据转化为医疗实践

2026-07-290
PRE
Genomic landscape of drug binding and pharmacogenetic variation across diverse populations using SNPdrug3D

使用SNPdrug3D分析不同人群中药物结合与药物遗传变异的基因组景观

2026-06-090
OAAI
Assessing the Feasibility and Acceptability of a Colorectal Cancer Risk Prediction Tool in Primary Care to Increase Screening Uptake in Singapore: A Multi-Methods Pilot Study

评估在新加坡初级保健中应用结直肠癌风险预测工具以增加筛查接受度的可行性与可接受性:一项多方法试点研究

2025-12-110
OA
BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes

BRCA1-、BRCA2-和PALB2相关的范可尼贫血:扩展疾病表型特征并预测杂合子乳腺癌风险的潜力

2025-10-300
PRE
Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

RAD51C、RAD51D和BRIP1基因杂合性胚系致病性变异携带者的管理:美国医学遗传学与基因组学学院(ACMG)的临床实践资源

2025-10-070
PRE
Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriers

亚洲BRCA1和BRCA2致病性变异携带者乳腺癌风险的polygenic risk score多基因风险评分

2025-09-300
OA
Metabolic variation reflects dietary exposure in a multi-ethnic Asian population

代谢变异反映了多民族亚洲人群的饮食暴露情况

2025-09-170
PRE
Breast cancer germline multigene panel testing in mainstream oncology based on clinical–public health utility: ESMO Precision Oncology Working Group recommendations

基于临床-公共卫生效用的主流肿瘤学中乳腺癌胚系多基因-panel检测:ESMO精准肿瘤学工作组建议

2025-06-150
PREAI
Metabolome-wide association identifies ferredoxin-1 (FDX1) as a determinant of cholesterol metabolism and cardiovascular risk in Asian populations

代谢组学关联分析确定了ferredoxin-1 (FDX1) 是亚洲人群中胆固醇代谢和心血管风险的决定因素。

2025-05-131
PRE
Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

ATM杂合性胚系致病性变异个体的管理:美国医学遗传学与基因组学学院(ACMG)的临床实践资源

2025-01-011
PRE